170 related articles for article (PubMed ID: 8339286)
1. Removal of breast cancer cells from bone marrow by in vitro purging with ether lipids and cryopreservation.
Dietzfelbinger HF; Kühn D; Zafferani M; Hanauske AR; Rastetter JW; Berdel WE
Cancer Res; 1993 Aug; 53(16):3747-51. PubMed ID: 8339286
[TBL] [Abstract][Full Text] [Related]
2. Differential cytotoxicity of an ether lipid on lymphoma and bone marrow cells and its role in purging malignant lymphoid cells from remission bone marrow contaminated with tumor cells.
Dietzfelbinger HF; Lang A; Oberberg D; Rastetter JW; Berdel WE
Exp Hematol; 1992 Feb; 20(2):178-83. PubMed ID: 1544386
[TBL] [Abstract][Full Text] [Related]
3. Purging leukemia remission marrows with alkyl-lysophospholipids, preclinical and clinical results.
Vogler WR; Olson AC; Berdel WE; Okamoto S; Glasser L
Prog Clin Biol Res; 1990; 333():1-18; discussion 19-20. PubMed ID: 2308973
[TBL] [Abstract][Full Text] [Related]
4. The alkyl-lysophospholipid, ET-18-OCH3 synergistically enhances the Merocyanine 540-mediated photoinactivation of leukemia cells: implications for the extracorporeal purging of autologous hematopoietic stem cells.
Yamazaki T; Sieber F
Bone Marrow Transplant; 1997 Jan; 19(2):113-9. PubMed ID: 9116607
[TBL] [Abstract][Full Text] [Related]
5. Elimination of leukemic cells by the combined use of ether lipids in vitro.
Okamoto S; Olson AC; Vogler WR
Cancer Res; 1987 May; 47(10):2599-603. PubMed ID: 3471316
[TBL] [Abstract][Full Text] [Related]
6. Correlation of ether lipid content of human leukemia cell lines and their susceptibility to 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.
Chabot MC; Wykle RL; Modest EJ; Daniel LW
Cancer Res; 1989 Aug; 49(16):4441-5. PubMed ID: 2743333
[TBL] [Abstract][Full Text] [Related]
7. Inhibition by an alkyl-lysophospholipid of the uptake of epidermal growth factor in human breast cancer cell lines in relation to epidermal growth factor internalization.
Kosano H; Takatani O
Cancer Res; 1989 Jun; 49(11):2868-70. PubMed ID: 2785846
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of estradiol uptake and transforming growth factor alpha secretion in human breast cancer cell line MCF-7 by an alkyl-lysophospholipid.
Kosano H; Yasutomo Y; Kugai N; Nagata N; Inagaki H; Tanaka S; Takatani O
Cancer Res; 1990 Jun; 50(11):3172-5. PubMed ID: 2334912
[TBL] [Abstract][Full Text] [Related]
9. The efficiency of tumor cell purging using immunomagnetic CD34+ cell separation systems.
Roots-Weiss A; Papadimitriou C; Serve H; Hoppe B; Koenigsmann M; Reufi B; Oberberg D; Thiel E; Berdel WE
Bone Marrow Transplant; 1997 Jun; 19(12):1239-46. PubMed ID: 9208119
[TBL] [Abstract][Full Text] [Related]
10. Reduction of epidermal growth factor binding in human breast cancer cell lines by an alkyl-lysophospholipid.
Kosano H; Takatani O
Cancer Res; 1988 Nov; 48(21):6033-6. PubMed ID: 3262419
[TBL] [Abstract][Full Text] [Related]
11. Ex vivo expansion of bone marrow from breast cancer patients: reduction in tumor cell content through passive purging.
Lundell BI; Vredenburgh JJ; Tyer C; DeSombre K; Smith AK
Bone Marrow Transplant; 1998 Jul; 22(2):153-9. PubMed ID: 9707023
[TBL] [Abstract][Full Text] [Related]
12. Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L).
Mollinedo F; Fernández-Luna JL; Gajate C; Martín-Martín B; Benito A; Martínez-Dalmau R; Modolell M
Cancer Res; 1997 Apr; 57(7):1320-8. PubMed ID: 9102220
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of purging clonogenic leukemia cells using ether lipid and hyperthermia for autologous bone marrow transplantation.
Min WS; Park HM; Han CH; Park JW; Kim CC; Kim DJ
Prog Clin Biol Res; 1992; 377():87-95. PubMed ID: 1438449
[No Abstract] [Full Text] [Related]
14. Decreased sensitivity to 1-O-octadecyl-2-O-methyl-glycerophosphocholine in MCF-7 cells adapted for serum-free growth correlates with constitutive association of Raf-1 with cellular membranes.
Samadder P; Arthur G
Cancer Res; 1999 Oct; 59(19):4808-15. PubMed ID: 10519389
[TBL] [Abstract][Full Text] [Related]
15. Toxic effects of alkyl-lysophospholipids on human bone marrow and de novo leukaemias. A short overview.
Wötzel M; Brachwitz H; Langen P; Thierbach V
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(6):771-6. PubMed ID: 1713880
[TBL] [Abstract][Full Text] [Related]
16. Autologous bone marrow transplantation in breast cancer: separation of clonogenic tumor cell colonies by gradient fractionation.
Kies MS; Gordon LI; Rosen ST; Kucuk O; Vriesendorp HM
Exp Hematol; 1988 Mar; 16(3):190-4. PubMed ID: 3276545
[TBL] [Abstract][Full Text] [Related]
17. The cytotoxicity of alkyl-lysophospholipid on clonogenic leukemia cells and on normal bone marrow progenitor cells is highly, but differentially, increased by cryopreservation.
Verdonck LF; Heesbeen EC; van Heugten HG; Staal GE; Rijksen G
Bone Marrow Transplant; 1992 Apr; 9(4):241-5. PubMed ID: 1600412
[TBL] [Abstract][Full Text] [Related]
18. Application of hypothermia to autologous stem cell purging.
Miyagi K; Yamazaki T; Tsujino I; Takahashi N; Koya Y; Masutani M; Sawada U; Horie T
Cryobiology; 2001 May; 42(3):190-5. PubMed ID: 11578118
[TBL] [Abstract][Full Text] [Related]
19. The antitumor ether lipid 1-Q-octadecyl-2-O-methyl-rac-glycerophosphocholine (ET-18-OCH3) inhibits the association between Ras and Raf-1.
Samadder P; Richards C; Bittman R; Bhullar RP; Arthur G
Anticancer Res; 2003; 23(3B):2291-5. PubMed ID: 12894505
[TBL] [Abstract][Full Text] [Related]
20. Use of amifostine in bone marrow purging.
Cagnoni PJ; Jones RB; Bearman SI; Ross M; Hami L; Franklin WA; Capizzi R; Schein PS; Shpall EJ
Semin Oncol; 1996 Aug; 23(4 Suppl 8):44-8. PubMed ID: 8783666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
